Bellerophon Therapeutics Dividend
Dividend criteria checks 0/6
Bellerophon Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.76 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Bellerophon Therapeutics (NASDAQ:BLPH) Will Have To Spend Its Cash Wisely
Jan 06
Bellerophon stock gains ~24% after getting FDA nod to reduce phase 3 study size
Sep 27Bellerophon Therapeutics GAAP EPS of -$0.43 beats by $0.17
Aug 15Is Bellerophon Therapeutics (NASDAQ:BLPH) In A Good Position To Invest In Growth?
Jan 18Bellerophon Therapeutics EPS misses by $0.01
Nov 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BLPH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BLPH's dividend payments have been increasing.
Dividend Yield vs Market
| Bellerophon Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BLPH) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (BLPH) | n/a |
Notable Dividend: Unable to evaluate BLPH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BLPH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BLPH's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BLPH has not reported any payouts.